Data / Drug companies / Trifecta Pharmaceuticals USA LLC
Trifecta Pharmaceuticals USA LLC: 106 products in the FDA NDC directory, labeler code 69396
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Trifecta Pharmaceuticals USA LLC (labeler code 69396) lists 106 products in the FDA National Drug Code Directory, covering 54 finished drugs by generic name. By type: 106 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on August 27, 2026.
The request: Watch Trifecta Pharmaceuticals USA LLC (FDA labeler code 69396): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 69396
- Products in commercial distribution
- 106
- Packages
- 175
- Finished drugs by generic name
- 54
- Prescription products
- 0
- Over the counter products
- 106
- Flagged as original packager
- 105 of 105 products that carry the flag
- Started marketing in the last 12 months
- 12
- Earliest marketing start
- March 10, 2015
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 100 | 94.3% |
| Generic drugs (ANDA) | 3 | 2.8% |
| Unapproved homeopathic products | 2 | 1.9% |
| Other unapproved drugs | 1 | 0.9% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 106 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Hydrocortisone | 12 | 171 |
| Bacitracin zinc | 5 | 39 |
| Mineral oil, petrolatum, phenylephrine hci | 4 | 5 |
| Zinc oxide | 4 | 595 |
| Benzalkonium chloride, lidocaine hci | 4 | 4 |
| Menthol 10%, methyl salicylate 15% | 3 | 4 |
| Clotrimazole | 3 | 98 |
| Ibuprofen | 3 | 190 |
| Glycerol, phenylephine, pramoxine, petrolatum | 3 | 2 |
| Bacitracin zinc, neomycin sulfate , polymyxin b sulfate. | 3 | 5 |
| Menthol | 3 | 263 |
| Lidocaine | 3 | 216 |
| Capsaicin | 3 | 66 |
| Bacitracin,neomycin,polymxin, pramoxine | 2 | 3 |
| Lidocaine hci | 2 | 7 |
| Povidone iodine 10% | 2 | 11 |
| Acetaminophen | 2 | 214 |
| Aspirin | 2 | 134 |
| Lanolin, petrolatum | 2 | 14 |
| Bacitracin zinc, neomycin sulfate , polymyxin b sulfate | 2 | 1 |
| Diphenhydramine hydrochloride 2%, zinc acetate 0.1% | 2 | 2 |
| Petrolatum | 2 | 74 |
| Dibucaine 1% | 1 | 2 |
| Phenylephrine, witch hazel | 1 | 2 |
| Family wellness bacitracin zinc, polymyxin b sulfate | 1 | 1 |
| Neomycinsulfate,polymyxinbsulfate,pramoxinehcl | 1 | 1 |
| Bacitracin,neomycin,polymyxinb,pramoxine | 1 | 1 |
| Bacitracin zinc, neomycin sulfate, polymyxin b sulfate | 1 | 44 |
| Bacitracinzinc,neomycinsulfate,polymxinbsulfate,pramoxinehci | 1 | 1 |
| Benzyl alcohol, lidocaine hci | 1 | 1 |
| Benzalkonium chloride towelettes | 1 | 1 |
| Bacitracin zinc, polymyxin b sulfate | 1 | 3 |
| Glycerin 20% | 1 | 1 |
| Family wellness tolnaftate | 1 | 1 |
| Family wellness bacitracin,neomycin,polymyxinb,pramoxine | 1 | 1 |
| Sodium chloride 0.9% | 1 | 1 |
| Lidocaine 4% | 1 | 45 |
| Calcium carbonate | 1 | 101 |
| Ichthammol | 1 | 2 |
| Benzalkonium chloride and lidocaine hci | 1 | 1 |
| Hydrogen peroxide 3.0% | 1 | 1 |
| Miconazole nitrate | 1 | 101 |
| Family wellness bacitracin,neomycin,polymyxinb,pramoxinehcl | 1 | 1 |
| Ichthammol 20% | 1 | 1 |
| Family wellness bacitracin, neomycin, polymyxin b | 1 | 1 |
| Alcohol | 1 | 293 |
| Benzalkonium chloride 0.13% | 1 | 19 |
| Benzocaine,resorcinol | 1 | 1 |
| Camphor, menthol | 1 | 35 |
| Family wellness clotrimazole | 1 | 1 |
| Tolnaftate | 1 | 99 |
| Hydrocortisone 1% | 1 | 15 |
| Lidocaine hci 2.0% | 1 | 1 |
| Tolnaftate 1% | 1 | 12 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Ointment | 41 | 38.7% |
| Cream | 37 | 34.9% |
| Gel | 8 | 7.5% |
| Tablet | 8 | 7.5% |
| Spray | 7 | 6.6% |
| Cloth | 1 | 0.9% |
| Solution | 1 | 0.9% |
| Patch | 1 | 0.9% |
| Salve | 1 | 0.9% |
| Stick | 1 | 0.9% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Povidone Iodine Swabstick | 69396-187 | Stick | Over the counter monograph drugs | August 27, 2026 |
| Benzalkonium Chloride | 69396-186 | Cloth | Over the counter monograph drugs | May 18, 2026 |
| Feminine Anti Itch Cream | 69396-183 | Cream | Over the counter monograph drugs | April 30, 2026 |
| Pain Relief Gel-Roll On | 69396-188 | Gel | Over the counter monograph drugs | April 27, 2026 |
| Pain Relief Gel-Roll On | 69396-185 | Gel | Over the counter monograph drugs | April 27, 2026 |
| Pain Relief Gel Roll On | 69396-184 | Gel | Over the counter monograph drugs | April 27, 2026 |
| Hemorrhoidal Cream with Lidocaine | 69396-181 | Cream | Over the counter monograph drugs | April 10, 2026 |
| Capsaicin Cream | 69396-180 | Cream | Over the counter monograph drugs | February 5, 2026 |
| Capsaicin Cream | 69396-179 | Cream | Over the counter monograph drugs | February 5, 2026 |
| Pain Relief | 69396-175 | Spray | Over the counter monograph drugs | January 25, 2026 |
| Lidocaine Pain Relief | 69396-178 | Spray | Over the counter monograph drugs | January 21, 2026 |
| Pain Relieving cleansing spary | 69396-177 | Spray | Over the counter monograph drugs | January 21, 2026 |
| Triple Antibiotic | 69396-162 | Ointment | Over the counter monograph drugs | October 14, 2025 |
| Hemorrhoidal Cream | 69396-171 | Cream | Over the counter monograph drugs | June 30, 2025 |
| Aspirin | 69396-173 | Tablet | Over the counter monograph drugs | June 9, 2025 |
| Bacitracin Zinc | 69396-163 | Ointment | Over the counter monograph drugs | June 5, 2025 |
| Tripleantibioticointmentandpainrelief | 69396-061 | Ointment | Over the counter monograph drugs | February 3, 2025 |
| Aspirin | 69396-158 | Tablet | Over the counter monograph drugs | August 24, 2024 |
| Triple Antibiotic plus Lidocaine | 69396-154 | Ointment | Over the counter monograph drugs | March 31, 2024 |
| Antiseptic | 69396-153 | Spray | Over the counter monograph drugs | March 18, 2024 |
| Always Save Bacitracin Zinc | 69396-148 | Ointment | Over the counter monograph drugs | March 15, 2024 |
| Hydrocortisone | 69396-149 | Ointment | Over the counter monograph drugs | March 10, 2024 |
| Pain Reliever Cream | 69396-151 | Cream | Over the counter monograph drugs | March 6, 2024 |
| Burn Cream | 69396-146 | Cream | Over the counter monograph drugs | March 6, 2024 |
| Pain Relief Gel-Patch | 69396-134 | Patch | Over the counter monograph drugs | February 28, 2024 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.